犬リンパ腫治療薬の世界市場インサイト、2029年までの予測Global Canine Lymphoma Treatment Market Insights, Forecast to 2029 悪性リンパ腫やリンパ肉腫は、犬などの犬種によく見られる腫瘍の一つで、犬の全腫瘍の約7~24%、犬の血球悪性腫瘍の約83%を占めています。犬のリンパ腫の治療薬は、腫瘍の治療と緩和に使用される薬剤です。 ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー悪性リンパ腫やリンパ肉腫は、犬などの犬種によく見られる腫瘍の一つで、犬の全腫瘍の約7~24%、犬の血球悪性腫瘍の約83%を占めています。犬のリンパ腫の治療薬は、腫瘍の治療と緩和に使用される薬剤です。市場分析・洞察:犬リンパ腫治療薬の世界市場 犬リンパ腫治療の世界市場は、2023年の百万米ドルから2029年には百万米ドルに達し、予測期間中に年平均成長率(CAGR)%で成長すると予測されます。 犬リンパ腫治療薬の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年の予測期間中にCAGR %で増加する見込みです。 犬リンパ腫治療の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中にCAGR %で増加すると考えられています。 犬リンパ腫治療のヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中にCAGR %で増加するとされています。 犬リンパ腫治療の世界の主要企業は、Oasmia Pharmaceutical、VetDC、Aratana Therapeutics、Merck、HylaPharmなどであり、2022年には世界の上位5社が収益面で約 %のシェアを持っていました。 レポートには、以下の内容が含まれます。 本レポートでは、犬リンパ腫治療薬の世界市場規模を概観しています。2018年~2022年の過去の市場収益データ、2023年の予測、2029年までのCAGRの予測など、世界市場の動向を分析します。 本レポートでは、犬リンパ腫治療薬の主要生産者を調査し、主要地域と国の収益も提供しています。犬リンパ腫治療の今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国に焦点を当てます。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータをもとに、犬リンパ腫治療薬の収益、主要企業の市場シェア、業界ランキングに焦点を当てます。世界の犬リンパ腫治療市場の主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業と市場戦略をより良い方法で位置づけるのに役立ちます。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、収益、成長率を分析しています。犬リンパ腫治療の収益、予測される成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。 Oasmia Pharmaceutical、VetDC、Aratana Therapeutics、Merck、HylaPharmなど、世界の主要プレイヤーの記述的な企業プロフィール。 会社別 オアスミア社製薬 ヴェトディック アラタナ セラピューティクス メルク ハイラファーマ タイプ別セグメント アルキル化剤 コルチコステロイド プリン類似物質 代謝拮抗薬(Antimetabolites 免疫調節剤 その他 用途別セグメント 動物病院・クリニック アンビュラトリーケア ホームケア その他 地域別 北アメリカ ユーエスエー カナダ ヨーロッパ ドイツ フランス 連邦王国 イタリア ロシア 北欧諸国 その他のヨーロッパ アジア太平洋 中国 日本 南朝鮮 東南アジア インド オーストラリア その他のアジア ラテンアメリカ メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ・中南米 トルコ サウジアラビア UAE MEAの残りの地域 章立て 第1章:報告書のスコープ、異なる市場セグメント(製品タイプ、アプリケーションなど)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介します。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。 第2章 犬リンパ腫治療薬の世界および地域レベルでの収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。 第3章:犬リンパ腫治療企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:各種市場セグメントを種類別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第5章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、開発可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。 第6章:北米:タイプ別、アプリケーション別、国別、各セグメント別の収益。 第7章:ヨーロッパ:タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第8章:中国 タイプ別、アプリケーション別、セグメント別の収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメントごとの収益。 第10章 中東、アフリカ、中南米 タイプ別、アプリケーション別、国別、各セグメントごとの収益。 第11章:主要企業のプロフィールを提供し、製品の説明や仕様、犬リンパ腫治療薬の収益、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章 アナリストの視点/結論 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Canine Lymphoma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Alkylating Agents 1.2.3 Corticosteroids 1.2.4 Purine Analogs 1.2.5 Antimetabolites 1.2.6 Immune Modulators 1.2.7 Others 1.3 Market by Application 1.3.1 Global Canine Lymphoma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Veterinary Hospitals and Clinics 1.3.3 Ambulatory Care 1.3.4 Homecare 1.3.5 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Canine Lymphoma Treatment Market Perspective (2018-2029) 2.2 Global Canine Lymphoma Treatment Growth Trends by Region 2.2.1 Canine Lymphoma Treatment Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Canine Lymphoma Treatment Historic Market Size by Region (2018-2023) 2.2.3 Canine Lymphoma Treatment Forecasted Market Size by Region (2024-2029) 2.3 Canine Lymphoma Treatment Market Dynamics 2.3.1 Canine Lymphoma Treatment Industry Trends 2.3.2 Canine Lymphoma Treatment Market Drivers 2.3.3 Canine Lymphoma Treatment Market Challenges 2.3.4 Canine Lymphoma Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Canine Lymphoma Treatment by Players 3.1.1 Global Canine Lymphoma Treatment Revenue by Players (2018-2023) 3.1.2 Global Canine Lymphoma Treatment Revenue Market Share by Players (2018-2023) 3.2 Global Canine Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Canine Lymphoma Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Canine Lymphoma Treatment Market Concentration Ratio 3.4.1 Global Canine Lymphoma Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Canine Lymphoma Treatment Revenue in 2022 3.5 Global Key Players of Canine Lymphoma Treatment Head office and Area Served 3.6 Global Key Players of Canine Lymphoma Treatment, Product and Application 3.7 Global Key Players of Canine Lymphoma Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Canine Lymphoma Treatment Breakdown Data by Type 4.1 Global Canine Lymphoma Treatment Historic Market Size by Type (2018-2023) 4.2 Global Canine Lymphoma Treatment Forecasted Market Size by Type (2024-2029) 5 Canine Lymphoma Treatment Breakdown Data by Application 5.1 Global Canine Lymphoma Treatment Historic Market Size by Application (2018-2023) 5.2 Global Canine Lymphoma Treatment Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Canine Lymphoma Treatment Market Size (2018-2029) 6.2 North America Canine Lymphoma Treatment Market Size by Type 6.2.1 North America Canine Lymphoma Treatment Market Size by Type (2018-2023) 6.2.2 North America Canine Lymphoma Treatment Market Size by Type (2024-2029) 6.2.3 North America Canine Lymphoma Treatment Market Share by Type (2018-2029) 6.3 North America Canine Lymphoma Treatment Market Size by Application 6.3.1 North America Canine Lymphoma Treatment Market Size by Application (2018-2023) 6.3.2 North America Canine Lymphoma Treatment Market Size by Application (2024-2029) 6.3.3 North America Canine Lymphoma Treatment Market Share by Application (2018-2029) 6.4 North America Canine Lymphoma Treatment Market Size by Country 6.4.1 North America Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Canine Lymphoma Treatment Market Size by Country (2018-2023) 6.4.3 North America Canine Lymphoma Treatment Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Canine Lymphoma Treatment Market Size (2018-2029) 7.2 Europe Canine Lymphoma Treatment Market Size by Type 7.2.1 Europe Canine Lymphoma Treatment Market Size by Type (2018-2023) 7.2.2 Europe Canine Lymphoma Treatment Market Size by Type (2024-2029) 7.2.3 Europe Canine Lymphoma Treatment Market Share by Type (2018-2029) 7.3 Europe Canine Lymphoma Treatment Market Size by Application 7.3.1 Europe Canine Lymphoma Treatment Market Size by Application (2018-2023) 7.3.2 Europe Canine Lymphoma Treatment Market Size by Application (2024-2029) 7.3.3 Europe Canine Lymphoma Treatment Market Share by Application (2018-2029) 7.4 Europe Canine Lymphoma Treatment Market Size by Country 7.4.1 Europe Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Canine Lymphoma Treatment Market Size by Country (2018-2023) 7.4.3 Europe Canine Lymphoma Treatment Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Canine Lymphoma Treatment Market Size (2018-2029) 8.2 China Canine Lymphoma Treatment Market Size by Type 8.2.1 China Canine Lymphoma Treatment Market Size by Type (2018-2023) 8.2.2 China Canine Lymphoma Treatment Market Size by Type (2024-2029) 8.2.3 China Canine Lymphoma Treatment Market Share by Type (2018-2029) 8.3 China Canine Lymphoma Treatment Market Size by Application 8.3.1 China Canine Lymphoma Treatment Market Size by Application (2018-2023) 8.3.2 China Canine Lymphoma Treatment Market Size by Application (2024-2029) 8.3.3 China Canine Lymphoma Treatment Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Canine Lymphoma Treatment Market Size (2018-2029) 9.2 Asia Canine Lymphoma Treatment Market Size by Type 9.2.1 Asia Canine Lymphoma Treatment Market Size by Type (2018-2023) 9.2.2 Asia Canine Lymphoma Treatment Market Size by Type (2024-2029) 9.2.3 Asia Canine Lymphoma Treatment Market Share by Type (2018-2029) 9.3 Asia Canine Lymphoma Treatment Market Size by Application 9.3.1 Asia Canine Lymphoma Treatment Market Size by Application (2018-2023) 9.3.2 Asia Canine Lymphoma Treatment Market Size by Application (2024-2029) 9.3.3 Asia Canine Lymphoma Treatment Market Share by Application (2018-2029) 9.4 Asia Canine Lymphoma Treatment Market Size by Region 9.4.1 Asia Canine Lymphoma Treatment Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Canine Lymphoma Treatment Market Size by Region (2018-2023) 9.4.3 Asia Canine Lymphoma Treatment Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Oasmia Pharmaceutical 11.1.1 Oasmia Pharmaceutical Company Details 11.1.2 Oasmia Pharmaceutical Business Overview 11.1.3 Oasmia Pharmaceutical Canine Lymphoma Treatment Introduction 11.1.4 Oasmia Pharmaceutical Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.1.5 Oasmia Pharmaceutical Recent Developments 11.2 VetDC 11.2.1 VetDC Company Details 11.2.2 VetDC Business Overview 11.2.3 VetDC Canine Lymphoma Treatment Introduction 11.2.4 VetDC Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.2.5 VetDC Recent Developments 11.3 Aratana Therapeutics 11.3.1 Aratana Therapeutics Company Details 11.3.2 Aratana Therapeutics Business Overview 11.3.3 Aratana Therapeutics Canine Lymphoma Treatment Introduction 11.3.4 Aratana Therapeutics Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.3.5 Aratana Therapeutics Recent Developments 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Canine Lymphoma Treatment Introduction 11.4.4 Merck Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.4.5 Merck Recent Developments 11.5 HylaPharm 11.5.1 HylaPharm Company Details 11.5.2 HylaPharm Business Overview 11.5.3 HylaPharm Canine Lymphoma Treatment Introduction 11.5.4 HylaPharm Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.5.5 HylaPharm Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMalignant lymphoma or lymphosarcoma are one of the common tumours in canine species such as dogs accounting for approximately 7-24% of all canine tumours and 83% of all canine blood cells malignancies. Canine lymphoma treatment are drugs used in the treatment and mitigation of tumours. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Canine Lymphoma Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Alkylating Agents 1.2.3 Corticosteroids 1.2.4 Purine Analogs 1.2.5 Antimetabolites 1.2.6 Immune Modulators 1.2.7 Others 1.3 Market by Application 1.3.1 Global Canine Lymphoma Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Veterinary Hospitals and Clinics 1.3.3 Ambulatory Care 1.3.4 Homecare 1.3.5 Others 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Canine Lymphoma Treatment Market Perspective (2018-2029) 2.2 Global Canine Lymphoma Treatment Growth Trends by Region 2.2.1 Canine Lymphoma Treatment Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Canine Lymphoma Treatment Historic Market Size by Region (2018-2023) 2.2.3 Canine Lymphoma Treatment Forecasted Market Size by Region (2024-2029) 2.3 Canine Lymphoma Treatment Market Dynamics 2.3.1 Canine Lymphoma Treatment Industry Trends 2.3.2 Canine Lymphoma Treatment Market Drivers 2.3.3 Canine Lymphoma Treatment Market Challenges 2.3.4 Canine Lymphoma Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Canine Lymphoma Treatment by Players 3.1.1 Global Canine Lymphoma Treatment Revenue by Players (2018-2023) 3.1.2 Global Canine Lymphoma Treatment Revenue Market Share by Players (2018-2023) 3.2 Global Canine Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Canine Lymphoma Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Canine Lymphoma Treatment Market Concentration Ratio 3.4.1 Global Canine Lymphoma Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Canine Lymphoma Treatment Revenue in 2022 3.5 Global Key Players of Canine Lymphoma Treatment Head office and Area Served 3.6 Global Key Players of Canine Lymphoma Treatment, Product and Application 3.7 Global Key Players of Canine Lymphoma Treatment, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Canine Lymphoma Treatment Breakdown Data by Type 4.1 Global Canine Lymphoma Treatment Historic Market Size by Type (2018-2023) 4.2 Global Canine Lymphoma Treatment Forecasted Market Size by Type (2024-2029) 5 Canine Lymphoma Treatment Breakdown Data by Application 5.1 Global Canine Lymphoma Treatment Historic Market Size by Application (2018-2023) 5.2 Global Canine Lymphoma Treatment Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Canine Lymphoma Treatment Market Size (2018-2029) 6.2 North America Canine Lymphoma Treatment Market Size by Type 6.2.1 North America Canine Lymphoma Treatment Market Size by Type (2018-2023) 6.2.2 North America Canine Lymphoma Treatment Market Size by Type (2024-2029) 6.2.3 North America Canine Lymphoma Treatment Market Share by Type (2018-2029) 6.3 North America Canine Lymphoma Treatment Market Size by Application 6.3.1 North America Canine Lymphoma Treatment Market Size by Application (2018-2023) 6.3.2 North America Canine Lymphoma Treatment Market Size by Application (2024-2029) 6.3.3 North America Canine Lymphoma Treatment Market Share by Application (2018-2029) 6.4 North America Canine Lymphoma Treatment Market Size by Country 6.4.1 North America Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Canine Lymphoma Treatment Market Size by Country (2018-2023) 6.4.3 North America Canine Lymphoma Treatment Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Canine Lymphoma Treatment Market Size (2018-2029) 7.2 Europe Canine Lymphoma Treatment Market Size by Type 7.2.1 Europe Canine Lymphoma Treatment Market Size by Type (2018-2023) 7.2.2 Europe Canine Lymphoma Treatment Market Size by Type (2024-2029) 7.2.3 Europe Canine Lymphoma Treatment Market Share by Type (2018-2029) 7.3 Europe Canine Lymphoma Treatment Market Size by Application 7.3.1 Europe Canine Lymphoma Treatment Market Size by Application (2018-2023) 7.3.2 Europe Canine Lymphoma Treatment Market Size by Application (2024-2029) 7.3.3 Europe Canine Lymphoma Treatment Market Share by Application (2018-2029) 7.4 Europe Canine Lymphoma Treatment Market Size by Country 7.4.1 Europe Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Canine Lymphoma Treatment Market Size by Country (2018-2023) 7.4.3 Europe Canine Lymphoma Treatment Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Canine Lymphoma Treatment Market Size (2018-2029) 8.2 China Canine Lymphoma Treatment Market Size by Type 8.2.1 China Canine Lymphoma Treatment Market Size by Type (2018-2023) 8.2.2 China Canine Lymphoma Treatment Market Size by Type (2024-2029) 8.2.3 China Canine Lymphoma Treatment Market Share by Type (2018-2029) 8.3 China Canine Lymphoma Treatment Market Size by Application 8.3.1 China Canine Lymphoma Treatment Market Size by Application (2018-2023) 8.3.2 China Canine Lymphoma Treatment Market Size by Application (2024-2029) 8.3.3 China Canine Lymphoma Treatment Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Canine Lymphoma Treatment Market Size (2018-2029) 9.2 Asia Canine Lymphoma Treatment Market Size by Type 9.2.1 Asia Canine Lymphoma Treatment Market Size by Type (2018-2023) 9.2.2 Asia Canine Lymphoma Treatment Market Size by Type (2024-2029) 9.2.3 Asia Canine Lymphoma Treatment Market Share by Type (2018-2029) 9.3 Asia Canine Lymphoma Treatment Market Size by Application 9.3.1 Asia Canine Lymphoma Treatment Market Size by Application (2018-2023) 9.3.2 Asia Canine Lymphoma Treatment Market Size by Application (2024-2029) 9.3.3 Asia Canine Lymphoma Treatment Market Share by Application (2018-2029) 9.4 Asia Canine Lymphoma Treatment Market Size by Region 9.4.1 Asia Canine Lymphoma Treatment Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Canine Lymphoma Treatment Market Size by Region (2018-2023) 9.4.3 Asia Canine Lymphoma Treatment Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type 10.2.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application 10.3.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country 10.4.1 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Canine Lymphoma Treatment Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Oasmia Pharmaceutical 11.1.1 Oasmia Pharmaceutical Company Details 11.1.2 Oasmia Pharmaceutical Business Overview 11.1.3 Oasmia Pharmaceutical Canine Lymphoma Treatment Introduction 11.1.4 Oasmia Pharmaceutical Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.1.5 Oasmia Pharmaceutical Recent Developments 11.2 VetDC 11.2.1 VetDC Company Details 11.2.2 VetDC Business Overview 11.2.3 VetDC Canine Lymphoma Treatment Introduction 11.2.4 VetDC Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.2.5 VetDC Recent Developments 11.3 Aratana Therapeutics 11.3.1 Aratana Therapeutics Company Details 11.3.2 Aratana Therapeutics Business Overview 11.3.3 Aratana Therapeutics Canine Lymphoma Treatment Introduction 11.3.4 Aratana Therapeutics Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.3.5 Aratana Therapeutics Recent Developments 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Canine Lymphoma Treatment Introduction 11.4.4 Merck Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.4.5 Merck Recent Developments 11.5 HylaPharm 11.5.1 HylaPharm Company Details 11.5.2 HylaPharm Business Overview 11.5.3 HylaPharm Canine Lymphoma Treatment Introduction 11.5.4 HylaPharm Revenue in Canine Lymphoma Treatment Business (2018-2023) 11.5.5 HylaPharm Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
QYResearch 社の最新刊レポート本レポートと同じKEY WORD(canine)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |